Volume 142, Issue 6, Pages (December 2012)

Slides:

Advertisements

Similar presentations

Treatment of Stage I and II Non-small Cell Lung Cancer

Advertisements

Colloquium on Therapy of Right Heart Failure

Silvestri Gerard A. , MD, FCCP, Rivera M. Patricia , MD, FCCP CHEST

Volume 143, Issue 5, Pages e93S-e120S (May 2013)

A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab Monica Khunger, MD Journal of Thoracic.

Volume 134, Issue 6, Pages (December 2008)

Jeffrey Bradley, MD Journal of Thoracic Oncology

Approach to the Ground-Glass Nodule

Figure 1. Suggested algorithm for locoregional lymph node staging in patients with non-metastatic NSCLC. CT, computed tomography; EBUS, endoscopic bronchial.

Special Treatment Issues in Non-small Cell Lung Cancer

Brandon Stone, MD, Victor S. Mangona, MD, Matthew D

The Lung Cancer Stage Page

Screening for Lung Cancer

Volume 143, Issue 5, Pages e93S-e120S (May 2013)

Treatment of Stage I and II Non-small Cell Lung Cancer

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

Disparities in Treatment of Patients with Inoperable Stage I Non–Small Cell Lung Cancer: A Population-Based Analysis Matthew Koshy, MD, Renuka Malik,

Michael C. Roach, MD, Gregory M. M. Videtic, MD, CM, FRCPC, Jeffrey D

Surgical quality of wedge resection affects overall survival in patients with early stage non–small cell lung cancer Gaurav S. Ajmani, MHS, Chi-Hsiung.

A Nomogram to Predict Recurrence and Survival of High-Risk Patients Undergoing Sublobar Resection for Lung Cancer: An Analysis of a Multicenter Prospective.

Has the 6-Min Walk Distance Run Its Course?

Brandon Stone, MD, Victor S. Mangona, MD, Matthew D

Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system Shamus R.

Oncologic Outcomes After Surgical Resection of Subcentimeter Non-Small Cell Lung Cancer Matthew J. Schuchert, MD, Arman Kilic, BS, Arjun Pennathur, MD,

Adult Bronchoscopy Training

Cornelis J. A. Haasbeek, MD, PhD, Frank J. Lagerwaard, MD, PhD, Ben J

A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab Monica Khunger, MD Journal of Thoracic.

Management of Pulmonary Nodules by Community Pulmonologists

Matthew J. Boyer, MD, PhD, Christina D. Williams, PhD, MPH, David H

Stereotactic Radiosurgery/Stereotactic Body Radiotherapy for Recurrent Lung Neoplasm: An Analysis of Outcomes in 100 Patients Arjun Pennathur, MD, James.

Components Necessary for High-Quality Lung Cancer Screening

Joshua E. Rosen, BASc, Michelle C

Juan A. Crestanello, MD, Richard C. Daly, MD

Volume 146, Issue 6, Pages (December 2014)

Adil Ayub, MD, Sadiq S. Rehmani, MD, Adnan M

The International Association for the Study of Lung Cancer International Staging Project on Lung Cancer Peter Goldstraw, MB, FRCS, John J. Crowley, PhD

Michelle C. Ellis, MD, Brian S. Diggs, PhD, John T. Vetto, MD, Paul H

Surgical Ventricular Restoration for Advanced Congestive Heart Failure: Should Pulmonary Hypertension Be a Contraindication? Nishant D. Patel, BA, Jason.

Radiological Changes After Stereotactic Radiotherapy for Stage I Lung Cancer Max Dahele, MBChB, MSc, David Palma, MD, Frank Lagerwaard, MD, PhD, Ben Slotman,

Volume 143, Issue 5, Pages e121S-e141S (May 2013)

Central versus Peripheral Tumor Location: Influence on Survival, Local Control, and Toxicity Following Stereotactic Body Radiotherapy for Primary Non–Small-Cell.

Treatment of Stage I and II Non-small Cell Lung Cancer

Lobar and sublobar resection with and without brachytherapy for small stage IA non– small cell lung cancer Hiran C. Fernando, FRCS, FRCSEd, Ricardo S.

Patterns of regional failure in stage III non-small cell lung cancer treated with neoadjuvant chemoradiation therapy and resection Shalini Garg, MD,

Surgical Considerations for the Management and Resection of Esophageal Gastrointestinal Stromal Tumors Matthew G. Blum, MD, Karl Y. Bilimoria, MD, Jeffrey.

The National Surgical Quality Improvement Program risk calculator does not adequately stratify risk for patients with clinical stage I non–small cell.

Characteristics Associated With the Use of Nonanatomic Resections Among Medicare Patients Undergoing Resections of Early-Stage Lung Cancer Anthony W.

Clinical outcomes and changes in lung function after segmentectomy versus lobectomy for lung cancer cases Bo Deng, MD, PhD, Stephen D. Cassivi, MD, Mariza.

A systematic review and meta-analysis of stereotactic body radiation therapy versus surgery for patients with non–small cell lung cancer Christopher.

Alex K. Bryant, BS, Robert C. Mundt, HSDG, Ajay P. Sandhu, MD, James J

Volume 155, Issue 1, Pages (January 2019)

Radiofrequency Ablation for the Treatment of Pulmonary Metastases

Impact of Pulmonary Function Measurements on Long-Term Survival After Lobectomy for Stage I Non-Small Cell Lung Cancer Mark F. Berry, MD, Chi-Fu Jeffrey.

The Association of Chronic Lung Disease With Early Mortality and Respiratory Adverse Events After Aortic Valve Replacement Juan A. Crestanello, MD, Robert.

High Risk for Thoracotomy but not Thoracoscopic Lobectomy

Jeffrey Bradley, MD Journal of Thoracic Oncology

Arman Kilic, BS, Matthew J. Schuchert, MD, Brian L

Marginal pulmonary function should not preclude lobectomy in selected patients with non–small cell lung cancer Matthew D. Taylor, MD, Damien J. LaPar,

Thoracic Surgery Survey on Lung Cancer Management

Impact of Sublobar Resection on Pulmonary Function: Long-Term Results from American College of Surgeons Oncology Group Z4032 (Alliance) Michael S. Kent,

Volume 133, Issue 4, Pages (April 2008)

Postesophagectomy Chylothorax: Incidence, Risk Factors, and Outcomes

Matthew J. Schuchert, MD, Omar Awais, DO, Ghulam Abbas, MD, Zachary D

Matthew J. Schuchert, MD, Brian L

Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery Raja M. Flores, MD The Journal.

Who should decide margin length in pulmonary excision of lung cancer?

Treatment of Stage III Non-small Cell Lung Cancer

Esophagectomy for T1 Esophageal Cancer: Outcomes in 100 Patients and Implications for Endoscopic Therapy Arjun Pennathur, MD, Andrew Farkas, BA, Alyssa.

A Review of First-Line Treatment for Small-cell Lung Cancer

Sebastien Gilbert, MD, David O. Wilson, MD, MPH, Neil A

Presentation transcript:

Volume 142, Issue 6, Pages 1620-1635 (December 2012) American College of Chest Physicians and Society of Thoracic Surgeons Consensus Statement for Evaluation and Management for High-Risk Patients With Stage I Non- small Cell Lung Cancer Jessica Donington, MD, MSCr, Mark Ferguson, MD, Peter Mazzone, MD, MPH, FCCP, John Handy Jr, MD, FCCP, Matthew Schuchert, MD, Hiran Fernando, MD, Billy Loo, MD, PhD, Michael Lanuti, MD, FCCP, Alberto de Hoyos, MD, FCCP, Frank Detterbeck, MD, FCCP, Arjun Pennathur, MD, John Howington, MD, FCCP, Rodney Landreneau, MD, Gerard Silvestri, MD, FCCP CHEST Volume 142, Issue 6, Pages 1620-1635 (December 2012) DOI: 10.1378/chest.12-0790 Copyright © 2012 The American College of Chest Physicians Terms and Conditions

Figure 1 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) diagram of records included in evaluation. The primary reasons for exclusion were data not relevant to the topic, data not specific to stage I non-small cell lung cancer, data limited to the treatment of adenocarcinoma in situ, duplicate data, or descriptive data without outcomes. PICO = population, intervention, comparison, and outcome. CHEST 2012 142, 1620-1635DOI: (10.1378/chest.12-0790) Copyright © 2012 The American College of Chest Physicians Terms and Conditions

Figure 2 Suggestions for minimal reporting in clinical trials evaluating treatment strategies for high-risk stage I non-small cell lung cancer. adeno = adenocarcinoma; BAC = adenocarcinoma in situ; CHF = congestive heart failure; CTCAE V4 = common terminology criteria for adverse events, version 4; CXR = chest radiograph; DLCO = diffusing capacity of lung for carbon monoxide; EBUS = endobronchial ultrasound; ECOG = Eastern Cooperative Oncology Group; EUS = endoscopic ultrasound; F/U = follow up; GGO = ground glass opacity; GTV = gross tumor volume; LOS = length of stay; LVEF = left ventricular ejection fraction; NOS = not otherwise specified; NYHA = New York Heart Association; PAP = pulmonary artery pressure; PFT = pulmonary function test; pHTN = pulmonary hypertension; PTV = planning treatment volume; QOL = quality of life; RECIST = response evaluation criteria in solid tumors; RFA = radio frequency ablation; RTOG = Radiation Therapy Oncology Group; RVSP = right ventricular systolic pressure; SBRT = stereotactic body radiotherapy; segment = segmentectomy; VATS = video-assisted thoracic surgery; wedge = wedge resection. CHEST 2012 142, 1620-1635DOI: (10.1378/chest.12-0790) Copyright © 2012 The American College of Chest Physicians Terms and Conditions